Ameriplan is categorized under Clinical Laboratory Instruments, Except Medical and Dental in New Baltimore, MI and active since 2005.
Ameriplan was established in 2005, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Clinical Laboratory Instruments, Except Medical and Dental business, which does work in the B2B market, and is classified as a Clinical Laboratory Instruments, Except Medical and Dental, under code number 333249 by the NAICS.
If you are seeking more information, feel free to contact Raymond Jernukian at the company’s single location by writing to 28339 Lange Road, New Baltimore, Michigan MI 48047 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Ameriplan |
| Contact Person: | Raymond Jernukian |
| Address: | 28339 Lange Road, New Baltimore, Michigan 48047 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Clinical Laboratory Instruments, Except Medical and Dental |
| SIC Code: | 3821 |
| NAICS Code: | 333249 |
| Share This Business: |
Ameriplan was started in 2005 to provide professional Clinical Laboratory Instruments, Except Medical and Dental under the SIC code 3821 and NAICS code 333249. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Raymond Jernukian for inquiries that concern Ameriplan by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Ameriplan can be found at the coordinates 42.658401,-82.82692 as well as the street address 28339 Lange Road in New Baltimore, Michigan 48047.
For its online presence, you may visit Ameriplan’s website at and engage with its social media outlets through on Twitter and on Facebook.